Short Interest in Arcadia Biosciences, Inc. (NASDAQ:RKDA) Expands By 45.3%

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the recipient of a significant growth in short interest during the month of March. As of March 13th, there was short interest totaling 23,692 shares, a growth of 45.3% from the February 26th total of 16,307 shares. Currently, 1.5% of the company’s stock are sold short. Based on an average daily trading volume, of 73,206 shares, the days-to-cover ratio is currently 0.3 days.

Arcadia Biosciences Stock Performance

Shares of Arcadia Biosciences stock traded up $0.02 during trading on Monday, reaching $1.49. The company’s stock had a trading volume of 367 shares, compared to its average volume of 33,192. Arcadia Biosciences has a one year low of $1.46 and a one year high of $6.71. The firm has a market cap of $3.07 million, a price-to-earnings ratio of -0.87 and a beta of 0.57. The business’s fifty day moving average price is $1.89 and its 200-day moving average price is $2.92.

Arcadia Biosciences (NASDAQ:RKDA) last announced its earnings results on Thursday, March 26th. The basic materials company reported ($0.98) earnings per share for the quarter, missing the consensus estimate of ($0.66) by ($0.32). Arcadia Biosciences had a negative net margin of 48.15% and a positive return on equity of 37.36%. The business had revenue of $0.90 million for the quarter, compared to the consensus estimate of $1.40 million.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arcadia Biosciences in a research report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Arcadia Biosciences presently has a consensus rating of “Sell”.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.